Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · March 15, 2023

Relationship Between Adverse Pregnancy Outcomes and Serum Anti-BP180 IgG Antibody Levels in Patients With Pemphigoid Gestationis

Journal of the European Academy of Dermatology and Venereology: JEADV


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the European Academy of Dermatology and Venereology: JEADV
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis
J Eur Acad Dermatol Venereol 2023 Feb 18;[EPub Ahead of Print], N Cordel, J Flament, F Jouen, V Seta, E Tancrède-Bohin, C Picard Dahan, MP Konstantinou, O Dereure, G Quéreux, C Prost, C Bedane, S Debarbieux, JP Lacour, A Dompmartin, E Wierzbicka-Hainaut, I Bourgault Villada, S Ingen Housz Oro, P Vabres, MA Richard, E Delaporte, A Pham-Ledard, MT Leccia, N Litrowski, C Michel, B Lagrange, M D'Incan, C Abasq, S Duvert-Lehembre, A Dupuy, I Alcaraz, AL Breton-Guitarian, F Lombart, E Estève, L Machet, P Del Giudice, M Fenot, T Belmondo, F Morin, O Guérin, J Benichou, B Tressières, P Joly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading